Eosera offers Earwax MD to healthcare professionals.
Eosera Inc., a biotechnology startup company specializing in ear care products, today announced its partnership with Oaktree Products, a distributor offering wholesale clinical supplies for audiologists, otolaryngologists (ENTs), and hearing instrument specialists.
Upon launching Earwax MD in April, Eosera’s CEO Elyse Dickerson said, “Healthcare professionals have been longing for a better solution for their patients with ear wax impaction. Currently available over-the-counter products are not providing enough relief. By partnering with Oaktree Products, Eosera ensures audiologists and other healthcare providers have easy access to this new, innovative product.”
Many people may be surprised to learn that approximately 18 million Americans have a medical procedure every single year just to have their earwax extracted. Additionally, earwax management is a constant challenge for audiologists and other healthcare professionals who need a quick and effective solution to use in-office, as well as to recommend for patients to use at-home for routine maintenance.
Oaktree Products carries two versions of Earwax MD—the 2-ounce bottle for in-office use and a smaller bottle available for healthcare professionals to resell to patients in their clinics.
“In clinical studies, 86 percent of patients experienced a complete clearance of earwax in 15-30 minutes. Earwax MD’s rate of effectiveness varies slightly among patients because each patient has a different type of earwax, but the product is proving itself to solve earwax impaction far better than anything currently on the market,” said Joe Griffin, Eosera’s co-founder and CSO.
“Over the last 25 years, Oaktree has been involved in teaching and training cerumen (earwax) management to the audiology profession,” Bob Kemp, CEO of Oaktree Products, said. “Historically, earwax softening agents have been formulated with carbamide peroxide. These products, like Debrox, usually require several days to produce results. The ability to soften and remove wax in minutes will make cerumen removal in the clinic so much easier and more efficient.”
Eosera Inc. is a majority woman-owned biotech company committed to developing products that address underserved medical needs. Eosera’s first product, Earwax MD, is a novel, patent-pending topical drop that uses a dual-action technology to dissolve impacted earwax. Earwax MD is clinically proven to perform in a single treatment, unlike alternatives that require multiple applications over time. Earwax MD is supported by scientific efficacy.
(Source: Eosera Inc.)